SkyQuest Technology Group recently introduced Cell Therapy Market study with in-depth overview, describing about the Product/Industry Scope and elaborates market outlook and status (2025-2032). The cell therapy market is anticipated to expand rapidly due to the rising incidence of chronic diseases, the shifting preference toward regenerative medicine, and the surging number of clinical trials related to cell-based therapies. More people are now suffering from chronic diseases and conditions worldwide. The International Diabetes Federation’s Diabetes Atlas shows that 573 million adults globally were living with diabetes in 2021. This number is expected to rise to 643 million in 2030 and 783 million in 2045.
Cell Therapy Market size was valued at USD 6.9 Billion in 2023 and is poised to grow from USD 8.38 Billion in 2024 to USD 39.81 Billion by 2032, growing at a CAGR of 21.5% during the forecast period (2024-2032).
The increase in funding for cell therapy clinical trials, the adoption of good practices for cell therapy manufacturing, and the success of cell therapy products have become key trends that are expanding firms in this market. The advancement in cell banking facilities along with the subsequent advancement in cell manufacturing, storage, and characterization has strengthened the market’s capability to handle large volumes across the world. Moreover, several organizations provide cell therapy characterization research and analysis services, and hence, contribute to enhancing the manufacturing of cell-based therapeutics. This has led to an enhancement of market revenues recently.
Get a Free Sample PDF of the Report – https://www.skyquestt.com/sample-request/cell-therapy-market
The 2025 global Cell Therapy Market report provides a comprehensive analysis of key industry players, market trends, pricing structures, and competitive dynamics, offering insights into the market landscape from 2025 to 2032. As a rapidly evolving sector, the Cell Therapy Market drives economic growth, innovation, and technological advancements through the development, production, and distribution of products and services. This report highlights the market’s growth potential and its impact on global industries, providing valuable insights for stakeholders, investors, and policymakers.
Detailed Segmentation and Classification of the report (Market Size and Forecast – 2032, Y-o-Y growth rate, and CAGR):
The Cell Therapy Market can be segmented based on several factors, including product type, application, end-user, and distribution channel.
The Global Cell Therapy Market is segmented by Technology, Cell Type, Therapy Type, Therapeutic Area, End user and region.
Based on Technology, the market is segmented into Somatic Cell Technology, Cell Immortalization Technology, Viral Vector Technology, Genome Editing Technology, Cell Plasticity Technology and Three-Dimensional Technology. Based on Type, the market is segmented into Autologous and Allogeneic.
Based on Cell Type, the market is segmented into Stem Cell (Bone Marrow, Blood, Umbilical Cord-Derived, Adipose-Derived Stem Cell, and Others (placenta, and nonspecific cells)), and Non-stem Cell.
Based on Therapy Type, the market is segmented into Allogeneic Therapies (Stem Cell Therapies (Hematopoietic Stem Cell Therapies, Mesenchymal Stem Cell Therapies) Non-Stem Cell Therapies (Keratinocytes & Fibroblast-based Therapies, Others), and Autologous Therapies (Stem Cell Therapies (BM, Blood, & Umbilical Cord-derived Stem Cells, Adipose Derived Cells, Others) Non-Stem Cell Therapies (T-Cell Therapies, CAR T Cell Therapy, T Cell Receptor (TCR)-based, Others) and Others).
Based on the Therapeutic Area, the market is segmented into Oncology, Cardiovascular Disease (CVD), Musculoskeletal Disorders, Dermatology, and Others.
Based on End User, the market is segmented into Hospitals & Clinics, Academic & Research Institutes, and Others.
Based on region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.
Cell Therapy Market – Regional Analysis:
North America emerged as the largest revenue market in 2023, with a share of approximately 58%, and the joint research activities between the research institution and the large pharmaceutical firm. Many developments are being witnessed in the region through these partnerships.
The Asia Pacific region is expected to witness a high growth rate during the forecast period owing to the growing demand for cell therapy. Some of these drivers include increased knowledge of new treatments, increased funding, and expected positive changes in government policies. For instance, in June 2022, Tessa Therapeutics Ltd. disclosed that it has closed series funding rounds worth USD 126 million for enhancing the research of the following generation cancer treatments. Likewise, the market in South Korea is poised to offer good growth prospects owing to the various strategies adopted by domestic and global players.
Top Market Players in Cell Therapy Market are:
Thermo Fisher Scientific, Inc. (US)
Merck KGaA (Germany)
Danaher Corporation (US)
Becton, Dickinson, and Company (US)
Lonza Group (Switzerland)
Sartorius AG (Germany)
Nkarta, Inc. (US)
Aurion Biotech (US)
S. BIOMEDICS (Europe)
MEDIPOST (South Korea)
Anterogen Co., Ltd. (South Korea)
JW Therapeutics (China)
JCR Pharmaceuticals Co., Ltd. (Japan)
Johnson & Johnson Services, Inc (US)
Bristol-Myers Squibb Company (US)
Gilead Sciences, Inc. (US)
Novartis AG (Switzerland)
Intellia Therapeutics (US)
Iovance Therapeutics (US)
CRISPR Therapeutics (Switzerland)
For a customized report, contact us to request personalization – https://www.skyquestt.com/speak-with-analyst/cell-therapy-market
Recent Developments Cell Therapy Market:
In March 2025, Indian vaccine maker Bharat Biotech said it will invest $75 million in its initial cell and gene therapy (CGT) plant in the southern state of Telangana. The new therapies are expected to hit the market in the coming three years, according to the company.
In March 2025, Alcon, announced the acquisition of a majority interest in Aurion Biotech, Inc., a clinical-stage entity with a focus on producing innovative cell therapies for eye disorders. Aurion will remain independent, but with complete support from Alcon to push its allogeneic cell therapy product candidate, AURN001, into Phase 3 clinical trials for corneal edema due to corneal endothelial disease in the second half of 2025. Aurion will also benefit from Alcon’s extensive resources in R&D, regulatory, medical, and commercial ophthalmology.
In March 2025, YASKAWA Electric Corporation and Astellas Pharma Inc. signed a final agreement to create a joint venture to create a cell therapy production platform powered by the dual-arm robot “Maholo.” The platform will also be made accessible to startups and academia to foster collaboration and boost innovation in the cell therapy industry.
Take Action Now: Secure Your Cell Therapy Market Today – https://www.skyquestt.com/buy-now/cell-therapy-market
Forward-Looking Insights
The Cell Therapy Market is set to experience sustained growth, fueled by technological advancements, broader global market access, and rising industry demand. With the industry addressing emerging challenges and capitalizing on new opportunities, it is expected to drive innovation and play a pivotal role in advancing global health and economic progress.
About Company:
SkyQuest Technology Consulting is a leading Strategy Consulting and Market Research firm, provides syndicated as well as customized research reports and growth consulting services, trusted by CXOs from Fortune 500 Companies, Start-ups, and MSMEs. The company comprises a team of expert research analysts and consultants, adding more than 1200 market research reports in our database each year. These reports offer in-depth analysis on 40+ industries & sub industries across 25 major countries worldwide, serving global clients across diverse industries. The company specializes in delivering customized intelligence, data-driven insights, and strategic advisory services that enable businesses to stay competitive and make informed decisions in rapidly evolving industries.
Contact Details:
SkyQuest Technology Group
USA (+1) 351-333-4748
Email: [email protected]
